Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: The ARIC study

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 217-222

  Alonso, Alvaro ^a   Tang, Weihong ^a   Agarwal, Sunil K ^b   Soliman, Elsayed Z ^c   Chamberlain, Alanna M ^a   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b IL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Epidemiology; Fibrinogen; Prognosis; von Willebrand factor

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN C; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ANTITHROMBIN III; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FACTOR VII; FACTOR VIII; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROGNOSIS; PROTEIN C; RISK FACTORS; STROKE; VON WILLEBRAND FACTOR;

EID: 84857043799     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.051     Document Type: Article

References (39)

1. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
2. E.J. Benjamin, P.-S. Chen, and D.E. Bild Prevention of atrial fibrillation: report from an NHLBI workshop Circulation 119 2009 606 618
3. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
4. T.J. Wang, M.G. Larson, and D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
5. A.R. Folsom, K.K. Wu, and W.D. Rosamond Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study Circulation 96 1997 1102 1108
6. Fibrinogen Studies Collaboration Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
7. H. Sohara, S. Amitani, and M. Kurose Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation J Am Coll Cardiol 29 1997 106 112
8. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation. A systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028
9. L.O. Mosnier, B.V. Zlokovic, and J.H. Griffin The cytoprotective protein C pathway Blood 109 2007 3161 3172
10. S. Cardin, D. Li, and N. Thorin-Trescases Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways Cardiovasc Res 60 2003 315 325
11. K.J. Mukamal, J.S. Tolstrup, and J. Friberg Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study) Am J Cardiol 98 2006 75 81
12. R.B. Schnabel, M.G. Larson, and J.F. Yamamoto Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community Circulation 121 2010 200 207
13. P.A. Wolf, J.B. Mitchell, and C.S. Baker Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
14. T. Watson, E. Shantsila, and G.Y.H. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
15. D.S.G. Conway, L.A. Pearce, and B.S.P. Chin Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation Circulation 107 2003 3141 3145
16. J. Heeringa, D.S.G. Conway, and D.A.M. Van der Kuip A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999 J Thromb Haemost 4 2006 1944 1949
17. D. Feng, R.B. D'Agostino, and H. Silbershatz Hemostatic state and atrial fibrillation (the Framingham Offspring Study) Am J Cardiol 87 2001 168 171
18. The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) study: design and objectives Am J Epidemiol 129 1989 687 702
19. A.C. Papp, H. Hatzakis, and A. Bracey ARIC hemostasis study, I: development of blood collection and processing system suitable for multicenter hemostatic studies Thromb Haemost 61 1989 15 19
20. Atherosclerosis Risk in Communities Study Manual 9: Hemostasis Determinations 1987 National Heart, Lung, and Blood Institute of the National Institutes of Health, Collaborative Studies Coordinating Center, University of North Carolina Chapel Hill, NC
21. L.E. Chambless, R. McMahon, and K. Wu Short-term intraindividual variability in hemostasis factors. The ARIC Study Ann Epidemiol 2 1992 723 733
22. A. Alonso, S.K. Agarwal, and E.Z. Soliman Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 158 2009 111 117
23. A.M. Chamberlain, S.K. Agarwal, and M. Ambrose Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 159 2010 850 856
24. E.Z. Soliman, R.J. Prineas, and D. Case Ethnic distribution of electrocardiographic predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities Study (ARIC) Stroke 40 2009 1204 1211
25. B.M. Psaty, T.A. Manolio, and L.H. Kuller Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461
26. W. Rosamond, A.R. Folsom, and L.E. Chambless Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort Stroke 30 1999 736 743
27. A.D. White, A.R. Folsom, and L.E. Chambless Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience J Clin Epidemiol 49 1996 223 233
28. J.A.H. Baecke, J. Burema, and J.E.R. Fritjers A short questionnaire for the measurement of habitual physical activity in epidemiological studies Am J Clin Nutr 36 1982 936 942
29. A. Barac, U. Campia, and J.A. Panza Methods for evaluating endothelial function in humans Hypertension 49 2007 748 760
30. J. Davignon, and P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 2004 III-27 III-32
31. J.B. Meigs, C.J. O'Donnell, and G.H. Tofler Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes Diabetes 55 2006 530 537
32. J. López-Sagaseta, R. Montes, and C. Puy Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity J Thromb Haemost 5 2007 1817 1824
33. J.-S. Bae, L. Yang, and C. Manithody The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells Blood 110 2007 3909 3916
34. F.L. Li-Saw-Hee, A.D. Blann, and D. Gurney Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function Eur Heart J 22 2001 1741 1747
35. A.R. Folsom, W.D. Rosamond, and E. Shahar Prospective study of markers of hemostatic function with risk of ischemic stroke Circulation 100 1999 736 742
36. A.R. Folsom, T. Ohira, and K. Yamagishi Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study J Thromb Haemost 7 2009 1774 1778
37. E.J. Benjamin, K.M. Rice, and D.E. Arking Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry Nat Genet 41 2009 879 881
38. K.K. Patton, P.T. Ellinor, and S.R. Heckbert N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study Circulation 120 2009 1768 1774
39. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150